N/A
Manufactured by BECTON DICKINSON AND COMPANY
28,872 FDA adverse event reports analyzed
Last updated: 2026-04-14
DEXTROSE MONOHYDRATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by BECTON DICKINSON AND COMPANY. The most commonly reported adverse reactions for DEXTROSE MONOHYDRATE include MYELOSUPPRESSION, OFF LABEL USE, NAUSEA, DRUG INEFFECTIVE, VOMITING. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DEXTROSE MONOHYDRATE.
Out of 12,135 classified reports for DEXTROSE MONOHYDRATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 28,872 FDA FAERS reports that mention DEXTROSE MONOHYDRATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include MYELOSUPPRESSION, OFF LABEL USE, NAUSEA, DRUG INEFFECTIVE, VOMITING, ACUTE KIDNEY INJURY. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list BECTON DICKINSON AND COMPANY in connection with DEXTROSE MONOHYDRATE. Always verify the specific product and NDC with your pharmacist.